- Virtual Race Day Details
- Twin Cities Race Registration
- Twin Cities Race Donations
- Twin Cities Friends for the Cure Fundraising
- Participant Center
- Brainerd Lakes Race for the Cure®
Breast Cancer Stories- Join us here as we continue to share stories that celebrate the women and men who inspire us all!
Rally for the Cure - Golf, tennis, dinner events and so much more...
Go Passionately Pink to help save lives! — Just wear pink, have fun and raise money to fight breast cancer. Be inspired by the multitude of ideas right here, or think of your own. There are so many creative ways to have fun and fight breast cancer.
- SUSAN G. KOMEN® MINNESOTA'S RESPONSE TO COVID-19
- Where Your Money Goes
- 2019 SGK Mission Impact Report
- Our Mission
- Mission in Action
- More Than Pink
- Thank You For Your Support
- Overview of Grantmaking Process
- Annual Information - Public Disclosure
- Charities Review Council
- Metastatic Breast Cancer Research
- 2020 Midwest Metastatic Breast Cancer Conference
Making an Impact in Your Community
- Susan G. Komen is the boldest community fueling the best science and making the biggest impact in the fight against breast cancer.
- Since 1998, Komen has awarded over $17.1 million in research grants in Minnesota to Mayo Clinic and Foundation, University of Minnesota at Duluth and University of Minnesota at Twin Cities.
- Komen Minnesota invested more than $800,000.00 in their local communities last year for early detection and treatment of breast cancer, breast health education and outreach. Nationwide, Komen Affiliates invested more than $58 million in their local communities.
- In 2017, Komen Minnesota helped provide: breast health education to 25,551 women and men; 4,035 screening mammograms and clinical breast exams; financial assistance to 1,422 women and men; patient navigation, complimentary therapies and emotional support to 1,136 women and men.
- Komen awarded $30.7 million in new research grants in 2017, growing our research investment to more than $956 million since our founding in 1982.
- Since our founding in 1982, Komen has touched many advances in breast cancer research, including discoveries such as tilmanocept, molecular breast imaging, ultrasound tomography and a new breast cancer predisposition gene, RECQL.
- Komen Affiliates are working tirelessly to preserve state screening programs across the country so that access to potentially life-saving screening is protected. Affiliates are also advocating for policies to reduce insurance barriers that shift costs to patients, preclude physician decision making and place unnecessary burdens on accessing care.
- To date, Komen has invested more than $2.2 billion in research and life-saving community programs. We are the only breast cancer organization with a comprehensive approach that touches research, advocacy and community support.
- Research: Beginning with a single grant for $28,000 in 1982, Komen has now invested more than $988 million in research. We currently manage more than 300 active research grants totaling nearly $200 million. After touching every major advance in breast cancer science, Komen is now focused on innovative research to bring treatments from the lab to the bedside quickly.
- We are the only breast cancer organization with a large network of community Affiliates.
- Komen is the only breast cancer organization attacking the disease on all fronts: in research, community outreach, education, advocacy and global work.
Komen’s network of Affiliates annually funds more than 800 community organizations providing education, screening, patient navigation and treatment assistance for those facing breast cancer.
- Annually Komen funds more than 500,000 screenings and provides financial and emotional support programs for more than 50,000 women and men.
- Susan G. Komen has changed how the world talks about and treats breast cancer (In 1982, people wouldn’t even say the words “breast cancer” aloud).
- A Komen grant has touched every major breast cancer breakthrough of the past 29 years.
- Funding for discoveries in genetics and biology has evolved into personalized, less invasive treatments for what was once a “one-treatment-fits-all” disease.
- Breast cancer mortality decreased from 1989-2015 by 39 percent in the U.S. due to a combination of early detection and effective treatment.
- Komen was the first to understand the power of communities and advocacy in breaking down barriers to breast cancer care.
- The Komen Advocacy Alliance has influenced U.S. federal and state decisions, fighting to ensure that women get access to the care they need.
- Breast cancer is the most common cancer among women in the U.S., accounting for 30 percent of newly diagnosed cancers.
- One in eight women in the U.S. will be diagnosed with breast cancer in her lifetime.
- Every 2 minutes, one case of breast cancer is diagnosed in the U.S.
- In 2020, more than 276,000 new cases of invasive breast cancer are expected to be diagnosed in women and more than 2,600 cases in men in the U.S.
- In 2020, about 42,000 women and men in the U.S. are expected to die from breast cancer.
- In Minnesota, an estimated 4,740 new cases of invasive breast cancer will be diagnosed among women in 2019, and 640 women will die of the disease.
- Every 50 seconds someone in the world dies from breast cancer. That's more than 1,700 women and men every day.
- On any given day at Komen- 582 people receive a free Komen funded mammogram and 343 people receive Komen funded patient navigation services.
- It is estimated more than 154,000 women are living with metastatic breast cancer.
- There are more than 3.8 million breast cancer survivors in the U.S.
- There are more than 6 million breast cancer survivors around the world.
Komen Minnesota Affiliate
Susan G. Komen Minnesota serves the entire state.
Susan G. Komen Twin Cities Race for the Cure®: May 10, 2020
Southdale Center, Edina
Susan G. Komen Brainerd Lakes Race for the Cure®: June 27, 2020
Phone: 952-746-1760 Website: www.komenminnesota.org